Four outstanding Queen’s professors have been named Canada Research Chairs, and two current Queen’s chairholders have had their positions renewed.
The Canada Research Chairs program invests approximately $265 million per year to make Canada one of the world’s top countries in research and development. Chairholders are leading researchers in their areas and improve Canada’s depth of knowledge in the natural sciences, health sciences, humanities, and social sciences.
“Queen’s success in earning four new Canada Research Chairs and two renewals is indicative of our leadership in the research behind some of the most pressing matters in the world today,” says Steven Liss, Vice-Principal (Research). “We’re very proud and fortunate to be able to support some of the world’s most accomplished and promising researchers.”
The university’s new chair recipients are Christopher Booth, Mark Daymond, Jeffrey Masuda and Dylan Robinson. Tucker Carrington and David Murakami Wood have had their appointments renewed.
Christopher Booth (Oncology) has been named the Tier 2 Canada Research Chair in Population Cancer Care. Dr. Booth is a medical oncologist with Kingston General Hospital, a clinician-scientist at the Cancer Centre of Southeastern Ontario, and an associate professor at Queen’s. The focus of Dr. Booth’s research program is to evaluate the effectiveness of new therapies in the general population and the quality of care delivered to patients in routine clinical practice.
“Being awarded the Canada Research Chair in Population Cancer Care is a tremendous honour and will make a major contribution to our research program,” says Dr. Booth. “I am fortunate at Queen’s to work within the Division of Cancer Care and Epidemiology, which is a world-class research unit dedicated to the study of cancer care and outcomes in the ‘real world.’”
[snip]…
For more information on Canada Research Chairs, follow this link.
The Canada Research Chairs (CRC) program has stood at the centre of a national strategy to make Canada one of the world’s top countries in research and development since 2000. The CRC program invests approximately $265 million per year to attract and retain some of the world’s most accomplished and promising minds. Canadian universities both nominate Canada Research Chairs and administer their funds. For each Tier 1 chair, the university receives $200,000 annually for seven years and for each Tier 2 chair, the university receives $100,000 annually for five years.
Queen’s distinguishes itself as one of the leading research-intensive institutions within Canada. The mission is to advance research excellence, leadership and innovation, as well as enhance Queen’s impact at a national and international level. Through undertaking leading-edge research, Queen’s is addressing many of the world’s greatest challenges, and developing innovative ideas and technological advances brought about by discoveries in science, engineering and health.